Results
1 -
4 of
4
(Click
here to explore results)
- Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells. Xu Li, Cuixia Gao, Yupei Wu, C.-Yan Cheng, Weiliang Xia, Zhiping Zhang
, J. Mater. Chem. B
, 2015
, 3
, 1556
- cRGD-modified nanoparticles of multi-bioactive agent conjugate with pH-sensitive linkers and PD-L1 antagonist for integrative collaborative treatment of breast cancer. Chenming Zou, Yuepeng Tang, Ping Zeng, Derong Cui, Majdi Al Amili, Ya Chang, Zhu Jin, Yuanyuan Shen, Songwei Tan, Shengrong Guo
, Nanoscale Horiz.
, 2023
, 8
, 870
- Molecular and nanoengineering approaches towards activatable cancer immunotherapy. Chi Zhang, Kanyi Pu
, Chem. Soc. Rev.
, 2020
, 49
, 4234
- Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy. Suah Yang, In-Cheol Sun, Hee Sook Hwang, Man Kyu Shim, Hong Yeol Yoon, Kwangmeyung Kim
, J. Mater. Chem. B
, 2021
, 9
, 3983